Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III study.

about

Psoriasis in Skin of Color: Insights into the Epidemiology, Clinical Presentation, Genetics, Quality-of-Life Impact, and Treatment of Psoriasis in Non-White Racial/Ethnic Groups.

P2860

Q48170767-55EBB8F0-6601-4849-8457-FBEB7023DAF3

P2860

Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III study.

Item

http://www.wikidata.org/entity/Q40217411

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy and safety of secukin ...... from ERASURE phase III study.

@en

type

Item

label

Efficacy and safety of secukin ...... from ERASURE phase III study.

@en

prefLabel

Efficacy and safety of secukin ...... from ERASURE phase III study.

@en

P1476

Efficacy and safety of secukin ...... from ERASURE phase III study.

@en

P2093

Chih-Jung Hsu

http://www.w3.org/2001/XMLSchema#string

Fang-Ju Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

IL-17 in Chronic Inflammation: From Discovery to Targeting.

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled perio

The IL-23/Th17 axis in the immunopathogenesis of psoriasis.

Molecular Phenotyping Small (Asian) versus Large (Western) Plaque Psoriasis Shows Common Activation of IL-17 Pathway Genes but Different Regulatory Gene Sets.

Psoriasis severity and the prevalence of major medical comorbidity: a population-based study

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment.

The roles of cells and cytokines in the pathogenesis of psoriasis.

Targeting IL-17 and TH17 cells in chronic inflammation.

Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.

P304

1129-1137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1346-8138.13900

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tsen-Fang Tsai

Nan-Lin Wu

P577

2017-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28493369

http://www.w3.org/2001/XMLSchema#string

Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III study.

about

P2860

P2860

Efficacy and safety of secukinumab in Taiwanese patients with moderate to severe plaque psoriasis: Subanalysis from ERASURE phase III study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698